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Available online 14 May 20149. Classiﬁcation of genetic diseases
There is no single comprehensive and satisfactory approach
for classiﬁcation of genetic diseases in view of the too many
parameters that have to be considered in this respect. Addi-
tionally, the need for accurate and ﬁnal characterization of
some aspects of these parameters can create marked overlap
between different aspects used for classiﬁcation. For example,
Marfan syndrome can be classiﬁed formally as an autosomal
dominant disease with a clinical spectrum including skeletal,
ocular, and cardiovascular abnormalities. The main underly-
ing pathology of the disease results from the synthesis of abnor-
mal Fibrillin-1 protein leading to defective synthesis of
connective tissue. Many pathological mechanisms contribute
to the pathogenesis of the Marfan syndrome including inade-
quate sequestration of transforming growth factor beta
(TGF-b) and deﬁcient assembly/biogenesis and maintenance
of the structural integrity of the framework of the elastic ﬁbers,
which constitutes a major component of the extracellular
matrix. Pathogenetic defects in the Marfan syndrome involve
abnormal synthesis, defective secretion, aberrant extracellular
matrix utilization and post-translation modiﬁcation defect
leading to misfolding of Fibrillin-1 protein, thus rendering it
ineffective for mediating its metabolic functions. Further anal-
ysis reveals that these defects are attributed to many pointmutations (missense mutations and single nucleotide deletions)
in the Fibrillin 1 or FBN1 gene on chromosome 15q21.1.
Accordingly, accurate and proper characterization and classi-
ﬁcation of the Marfan syndrome, like most other genetic dis-
eases, will have to take into consideration all these formal/
clinical/pathological/pathogenetic and molecular aspects of
the disease. However, a simple comprehensive approach
deﬁned by quantitative contribution of the genetic defect in
causation of the disease seems more plausible and most useful
in this regard for many reasons headed by availing accurate
diagnostic and prognostic guidelines indispensable for provid-
ing proper management plans, including therapy and counsel-
ing advice, to affected individuals and their related family
members. Relevant classiﬁcation approaches to genetic dis-
eases include the following approaches, that have to be con-
ceived in view of the many overlaps between the multiple
aspects of different parameters used for this scheme of catego-
rizing and classiﬁcation of genetic diseases. Table 6 summa-
rizes classiﬁcation based on molecular post-mutational
defects in different stages of gene function, that constitute
the bases of etiological classiﬁcation of genetic disorders,
Table 7 summarizes common, relatively comprehensive, classi-
ﬁcation approaches to genetic disorders, viz. etiological/patho-
logical/formal and clinical classiﬁcation, and Table 8
summarizes some common, currently deﬁned pathogenetic
mechanisms and pathophysiological alterations involved in
pathogenesis of genetic disorders, which constitute the bases
of pathological classiﬁcation of these diseases.
(1) Etiological classiﬁcation:
This approach is based on the nature/magnitude and type(s)
of mutation(s) affecting the disease gene as well as on different
pathogenetic mechanism(s) mediating the pathogenesis of the
disease. Inclusion of the pathophysiological alterations that
Table 6 Post-mutational molecular mechanisms that disturb different stages of gene function.
1. Deletion of part of a gene, one or many genes, part of a chromosome, one or more chromosomes or even the whole genome
2. Rearrangement/instability of the genetic material
3. Damage/inaccessibility of promoter of the gene
4. Deﬁcient/defective synthesis of transcription factors (microRNAs and nucleoproteins)
5. Deﬁcient/defective transcription of mRNA
6. Deﬁcient/defective post-transcriptional modiﬁcations of primary heterogeneous mRNA
7. Deﬁcient/defective translation of mRNA leading to deﬁcient/defective production of gene products
8. Deﬁcient/defective post-translational structural modiﬁcations of synthesized proteins
9. Deﬁcient/defective post-translational targeting/traﬃcking of synthesized proteins
10. Deﬁcient/defective synthesis of regulatory signal transducing proteins/biomolecules
11. DNA repair defects
12. Damage to DNA-associated proteins
13. Defective synthesis of regulatory factors controlling cell division, intercellular contact, cell growth, etc
14. Defective regulation of transposon stability: spontaneous mutations and teratogenic malformations
312 M.S.Z. Salemdirectly underlie actual development of the various clinical/
pathological abnormalities of the disease is important for ﬁnal
characterization of the disease in question. For example, Mar-
fan syndrome can be etiologically characterized as a connective
tissue disorder due to defective synthesis of Fibrillin-1 protein
as a result of point mutations of the Marfan, or FBN1, gene.
This detailed classiﬁcation approach is crucial for accurate
molecular diagnosis of the disease which is a prerequisite step
for availing prenatal diagnosis, offering possible prenatal pro-
phylactic and/or therapeutic interventions and provision of
accurate counseling advice to concerned individuals.
(2) Pathophysiological classiﬁcation:
Classiﬁcation of genetic diseases according to the nature of
the abnormal pathogenetic mechanism(s) that underlies patho-
genesis of the disease is indispensable for understanding how the
disease phenotype develops, how complications ensue and pos-
sible prognostic outcomes. More importantly, knowing how
diseases develop and progress allows for hypothesizing, postu-
lating and designing speciﬁc prophylactic and/or therapeutic
approaches to combat pathogenesis of the disease, arrest its pro-
gression and alleviatemuch of the sufferings of affected patients.
The number of different pathogenetic mechanisms involved
in the development of different categories of genetic disorders
seems innumerable. This is attributed to the extreme complex-
ity of the genetic regulatory processes exerted by the genome on
the proteome responsible for mediation of every and all life
activities in living cells. Gene function is a multistage process
consisting of many consecutive and coherent steps, viz. gene
activation/transcription/post-transcription modiﬁcations of
mRNA/translation/post-translation modiﬁcations of synthe-
sized proteins/trafﬁcking and targeting of synthesized proteins
to their cellular locations or extracellular destinations, and
ﬁnally, suppression of transcription after synthesis of required
amounts of the gene product. Multiple speciﬁc pathogenetic
mechanisms have been identiﬁed for nearly every step of every
stage of gene function. The list of pathogenetic mechanisms and
pathophysiological alterations involved in, and responsible for,
pathogenesis of genetic diseases comprises multitudes of diverse
and interrelated mechanisms, as can be depicted in Table 8.
(3) Formal classiﬁcation:
Formal classiﬁcation of genetic disorders is determined by
many parameters that can be deduced and depicted from
extended family pedigrees constructed for affected patients
and their family members. These parameters include the
pattern(s) of inheritance, the nature of occurrence (sporadicversus familial), the heritability (heritable versus non-heritable)
and inherited versus non-inherited newly acquired disorders due
to fresh or de novo mutations in the zygote or in early embryonic
cells. Formal classiﬁcation of genetic diseases is mandatory for
providing proper counseling advice to concerned individuals, as
well as for providing guiding clues to proper diagnostic investiga-
tions relevant to the disease in question.
(4) Clinical classiﬁcation:
This classiﬁcation approach is deﬁned by the speciﬁc, or
pathognomonic, phenotype of affected individuals. It takes
into consideration the nature of the disease whether it is an iso-
lated (affecting one single tissue/organ or part of the body), a
pleiotropic disorder with affection of many tissues/organs/
many parts of the body due to the pleiotropic effects of the dis-
ease gene or a syndromic disorder presenting with affection of
multiple related or unrelated tissues/organs or parts of the body.
As referred to previously, no single satisfactory approach
exists for classiﬁcation of genetic diseases. The following clas-
siﬁcation scheme, however, tries to combine as much of the dif-
ferent approaches as possible in order to simplify categorization,
suggest diagnostic investigations and offer counseling advice to
affected patients and their concerned family members.
9.1. Single gene disorders
Single gene disorders are caused by deleterious effects of single
mutant genes. Nuclear single gene disorders are caused by
genes located on chromosomes and inherited in a classical/tra-
ditional or Mendelian way. They comprise both autosomal dis-
orders due to mutant genes located on the autosomes,
chromosomes 1–22, and sex linked disorders caused by genes
located on either the X chromosome, X-linked diseases, or
on the Y chromosome, Y-linked diseases. Mitochondrial single
gene disorders, as the name implies, are caused by mutant
mitochondrial genes and have different patterns of non-classi-
cal/non-traditional or non-Mendelian inheritance. Mutant
genes cause genetic disorders via one of three different and dis-
tinctive mechanisms, viz. synthesis of defective gene product,
deﬁcient synthesis of gene product or disturbed regulation of
one or more physiological cellular activities. Though the exact
number of genetic diseases is not known, because the list of
disease genes is progressively expanding, the majority of
currently deﬁned genetic diseases are single nuclear autosomal
gene defects. Additionally, nearly 70% of these defects are
caused by point mutations of causative mutant genes.
Table 7 Classiﬁcation of genetic disorders.
1. Etiological 
classification
1. Nuclear gene mutations
a. Point mutations
b. Small mutations
c. Gross mutations
d. Genomic mutations (Involving the whole genome): triploidy, tetraploidy
2. Mitochondrial gene mutations 
1. Exclusive genetic disorders
a. Single gene disorders
b. Polygenic disorders
1. Few mutant genes
2. Chromosomal abnormalities 
a. Numerical abnormalities: trisomy, monosomy, hypodiploidy,
heperdiploidy
b. Structural abnormalities: deletion, translocation, inversion, chromosome
breakage, isochromosome formation, ring chromosome formation. 
c. Microdeletion syndromes
d. Microduplication syndromes
e. Microtriplication syndromes
f. Telomere region abnormalities
2. Multifactorial disorders (Environmental teratogen + susceptible genetic
constitution).
2. Pathophysiological
classification
A. Pathogenetic mechanisms
B. Pathophysiological alterations
3. Formal 
classification
A. Pattern of inheritance
1. Mendelian/classic/traditional patterns 
a. Autosomal dominant
b. Autosomal recessive
c. X-liked dominant
d. X-linked recessive
e. Y-linked
f. Co-dominant inheritance.
2. Non-Mendelian/non-classic/non-traditional patterns
a. Genic imprinting
b. Genomic imprinting
c. Di-, Tri-, Tetra-, Penta-, Hexa-triplet expansion defects
d. Uniparental disomy (Isodizomy/Heterodisomy)
e. Mitochondrial inheritance
f. Germ line (gonadal) mosaicism
g. Micro deletion/duplication/triplication disorders
h. Multifactorial disorders.
B. Pattern of occurrence
1. Sporadic (only case in the family)
2. Familial (many similar cases in the family).
C. Heritable and non-heritable disorders.
D. Inherited and acquired disorders.
4. Clinical 
classification
1. Isolated disorders: affection of single organ, tissue, part of the body
2. Pleiotropic disorders: affection of many tissues, organs, parts of the body
3. Syndromic disorders: affection of multiple related or unrelated parts
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Polygenic disorders result from combined defects in many
mutant genes. The co-participation of either different or func-
tionally related genes in pathogenesis of clinically distinctive
polygenic disease phenotypes can be interpreted in view of
the mediation of all metabolic networks in the cell by large
numbers of proteins and enzymes synthesized under direct
control of structural genes. Accordingly, development of
polygenic diseases caused by pathophysiological disturbances
in one or more of these networks requires defective or deﬁcient
functions of many genes responsible for regulating these
networks. The list of polygenic diseases comprises large
numbers of diseases, some of which are of major health
concern, e.g. hypertension, coronary heart disease, diabetes
mellitus, bronchial asthma, epilepsy, many types of common
cancers, schizophrenia and manic depressive psychosis.9.2.1. Chromosomal aberrations
Chromosomal aberrations constitute an important category of
polygenic disorders caused by defects affecting large numbers,
sometimes tens to hundreds, of different separate as well as of
functionally related genes. This particular category of genetic
disorders might be caused by different pathogenetic mecha-
nisms including structural defects e.g. terminal/interstitial dele-
tions, duplications, insertions, unidirectional/mutual translocations,
isochromosome formation, pericentric/paracentric inversions,
and many others, and numerical aberrations like trisomy,
monosomy, hypodiploidy and hyperdiploidy.9.2.2. Microdeletion syndromes, contiguous gene syndromes
or segmental aneusomy (Table 9)
Microdeletion syndromes, contiguous gene syndromes or
segmental aneusomy (Table 9), constitute an important
314 M.S.Z. Salemsubcategory of chromosomal abnormalities that involve the
deletion of a minute segment including multiple contiguous
genes on a localized region of a chromosome. These syndromes
are characterized by distinctive recognizable clinical pheno-
types with wide spectra of heterogeneous pleiotropic manifes-
tations. Though the pleiotropic phenotype of a contiguous
gene syndrome can be caused by the deletion of a speciﬁc
pleiotropic gene whose product is participating in mediating
multiple functions, it can be due to the deletion of a number
of tightly linked contiguous genes cooperatively participating
in mediating speciﬁc functions, i.e. functionally related genes.Table 8 Common pathogenetic/pathophysiological mecha-
nisms of genetic diseases.
1. Loss/damage/duplication/inactivation of nuclear genes
2. Mutation of mitochondrial genes (mitDNA): mitochondrial
disorders
3. Deﬁcient/defective DNA replication/repair
4. Triplet repeat expansion disorders
5. Loss/acquisition/damage of chromosomes
6. Deﬁcient transcription of mRNA
7. Transcription of defective mRNA
8. Deﬁcient/defective post-transcription mRNA repair/editing
9. Deﬁcient/defective post-transcription modiﬁcations of mRNA
10. Deﬁcient translation of proteins
11. Translation of structurally defective proteins
12. Deﬁcient/defective post-translation modiﬁcation of proteins
13. Deﬁcient/defective post-translation repair of misfolded proteins
14. Deﬁcient/defective post-translation targeting and traﬃcking of
proteins
15. Deﬁcient/defective regulation of cell growth
16. Deﬁcient/defective regulation of cell division
17. Deﬁcient/defective regulation of cell diﬀerentiation
18. Deﬁcient/defective regulation of cell migration
19. Deﬁcient/defective regulation of intercellular contact and cell
movement
20. Deﬁcient/defective apoptosis/selection repair
21. Deﬁcient/defective regulation of cell architecture and cell
cytoskeleton
22. Imprinting defects: genomic imprinting disorders and genic
imprinting diseases
23. Deﬁcient/defective regulation of cellular functions: signal
transduction defects
24. Deﬁcient/defective transport across cell membranes: transport
defects
25. Deﬁcient/defective transport across cell pores: chanellopathies
26. Deﬁcient/defective secretion of gene products: protein/enzyme
deﬁciency disorders
27. Deﬁcient/defective catabolism of metabolic waste products:
storage disorders
28. Deﬁcient/defective positioning of structural proteins: cell
cytoskeleton disorders
29. Deﬁcient/defective regulation of intracellular metabolic
networking
30. Deﬁcient/defective production of cellular energy: oxidative-
phosphorylation disorders
31. Ubiquitination/proteasome degradation defects
32. Apoptosis defects
33. Defective regulation of ciliary movements: ciliary dyskinesia
disorders
34. Defective synthesis of nuclear envelope: laminopathies/nuclear
envelopathies
35. Defective regulation of embryonic/fetal development:
congenital malformationsDue to paucity of information as regards the underlying path-
ogenetic mechanisms responsible for the development of mic-
rodeletion syndromes, it is often not possible to decide
whether a speciﬁc syndrome phenotype is caused by deﬁ-
cient/defective synthesis of a product secondary to deletion
of one single gene or by deﬁcient/defective synthesis of many
products secondary to concurrent deletions of multiple genes
at the microdeletion region.
Many observations suggest that possible etiological rela-
tionships might exist between microdeletion-inducing mecha-
nism(s) and imprinting. For instance, 5–10% of cases with
neuroﬁbromatosis 1 (NF 1) are caused by microdeletions in
the q11.2 region of chromosome 17 (17q11.2) and about
80% of these cases are due to microdeletions of maternal origin
due to unequal crossing over in maternal meiosis 1 [1]. Also,
cases with Sotos syndrome have been found to have a prefer-
ential paternal origin of microdeletions caused by prezygotic
chromosome or chromatid rearrangements [2]. Similarly,
parental origin effect in a classic form of Cockayne syndrome
due to a de novo microdeletion of maternal origin spanning
the ERCC6 gene was detected [3]. Other relevant ﬁndings
pointing to a possible relationship between imprinting and
microdeletion include the detection of a novel microdeletion
in the IGF2/H19 imprinting control center that deﬁnes a recur-
rent mutation mechanism in familial Beckwith–Wiedemann
syndrome [4] and the participation of both mechanisms inde-
pendently in pathogenesis of cases of Prader–Willi syndrome.
However, these ﬁndings might reveal a possible relationship
between imprinting and over dosage states of microduplication
and microtriplication rather than with haplo-insufﬁciency
states like microdeletion syndromes. In view of the, still, unde-
ﬁned biological signiﬁcance of imprinting and the poorly
deﬁned mechanisms of this critical phenomenon which plays
a major role in normal embryonic/fetal development in mam-
mals as well as in other non-mammal species, imprinting can
be looked at as an important potential genomic regulatory
mechanism aiming at controlling genomic overdose imbal-
ances that are prone to happen due to massive genetic over
expression during critical periods of embryonic and fetal devel-
opment. Defective genomic regulation of imprinting control
centers might result in faulty expression and persistence of
the defect(s) all through post-natal life. This assumption makes
it quite feasible to hypothesize that imprinting disorders could
be considered as sex-determined, autosomal or X-linked/
Y-linked, dominant disorders consider in view of their partic-
ular pattern of occurrence. A perplexing concept in this regard
is the assumption that genetic imprints acquired during paren-
tal gametogenesis are maintained during pre-implantation
development when reprogramming of the overall genome
occurs [5], since there is neither a need nor a signiﬁcance of
overall genome reprogramming. There is no evidence in
support of this assumption. Also, none of the regulatory
mechanisms responsible for genome reprogramming have been
deﬁned, or even postulated.
However, a lot of research is needed in order to reveal the
real biological signiﬁcance and exact molecular mechanisms of
both phenomena of genic and genomic imprinting.
9.2.3. Microduplication syndromes
Microduplication syndromes another subcategory of minute
structural chromosomal abnormalities, are caused by duplica-
Table 9 Microdeletion syndromes.
Syndrome Phenotypic features Cytogenetic
location
Prader–Willi syndrome Hypotonia, hyperphagia, obesity, short stature, small hands
and feet, hypopigmentation, mental retardation
15qll-ql3
Angelman syndrome Hypotonia, microcephaly, ataxic gait, inappropriate
laughter, seizures, hypopigmentation, mental retardation
15qll-ql3
Williams syndrome Dysmorphic facies, infantile hypercalcemia, congenital
heart disease, gregarious personality, premature aging of the
skin, mental retardation
7qll.23
Miller–Dieker syndrome Type I lissencephaly, dysmorphic facies 17pl3.3
Velo-Cardio Facial
syndrome (Del-22q)
Abnormal facies, cleft palate, thymic hypoplasia,
hypocalcemia, heart defect (conotruncal defect)
22qll
Langer-Giedion syndrome Tricho-rhino-phalangeal Syndrome (sparse hair, bulbous
nose, cone-shaped phalangeal epiphyses), multiple
exostoses, mental retardation
8q24.1
Rubinstein-–Taybi
syndrome
Dysmorphic facies, broad thumbs and ﬁrst toes, mental
retardation
16pl3.3
Alpha-thalassemia and
mental retardation (ATR-
16) syndrome
Dysmorphic facies, alpha-thalassemia, mental retardation 16pl3.3
Alagille syndrome Dysmorphic facies, chronic cholestasis, vertebral arch
defects, pulmonic stenosis
20pll.23-pl2.2
Albrights hereditary
osteodystrophy-like
syndrome
Short stocky build, abnormal facies, developmental delay,
brachy-meta-phalangism, seizures
2q37
AWTA (WAGR)
syndrome
Aniridia, Wilms Tumor, genitourinary dysplasia, mental
retardation
11pl3
Smith–Magenis syndrome Dysmorphic facies, behavioral abnormalities, self
destructive behavior, peripheral neuropathy, mental
retardation
17p11.2
(FLII, TOP3,
SHMT1)
Greig-Cephalopoly-
syndactyly syndrome
Craniosynostosis, polysyndactyly, mental retardation 7pl3
Cat-Eye syndrome Coloboma, choanal atresia, learning disabilities, mental
retardation
22qll.2
Diamond-–Blackfan
syndrome
Red blood cell hypoplasia, macrocephaly, hypotonia and
psychomotor retardation
19ql3.2
van der Woude syndrome Cleft Lip With or Without Cleft Palate; Bilateral Lip Pits;
Hypodontia
1q32-lq1
NF1 Microdeletion
syndrome
Neuroﬁbromatosis, early onset of cutaneous
neuroﬁbromas, facial dysmorphism, learning disabilities,
mental retardation
17qll.2
Y chromosome micro–
deletion syndrome
Unilateral cryptorchidism, idiopathic infertility Yql3
Distal 22q microdeletion Hypotonia, severe language delay, mild facial dysmorphism 22ql3-22qter
Xp21 Deletion Muscular dystrophy, glycerol kinase deﬁciency, congenital
adrenal hypoplasia, mental retardation
Xp21
1p36 Deletion syndrome Hypotonia, developmental delay, growth abnormalities,
craniofacial dysmorphism, minor cardiac malformations
1p36
Saethre–Chotzen
syndrome
Learning diﬃculties, short stature, craniosynostosis, eyelid
anomalies, limb anomalies, breast cancer.
7p21.1
10q26.13
Retinoblastoma 13q14
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contiguous genes. Similar to microdeletion syndromes, many
microduplication syndromes with speciﬁc recognizable pheno-
types have been deﬁned (Table 10).
9.2.4. Microtriplication syndromes
Microtriplication syndromes due to triplication of minute
chromosomal segments may emerge as a new category of
structural chromosomal aberrations. Currently, few microtri-
plication syndromes caused by this pathogenetic mechanism
have been identiﬁed, e.g. microtriplication involving theWilliams–Beuren region at (7q11.23) with clinical features sim-
ilar to, but more severe than, those observed in patients with a
duplication of this region [6] and microtriplication of region
(11q24.1) presenting a distinctive phenotype with short stature,
characteristic facial features, keratoconus, overweight and
intellectual disability [7].
Submicroscopic chromosomal abnormalities detectable as
microdeletions/microduplications/microtriplications represent
localized genomic rearrangements. Though genetic microdu-
plications/microtriplications might be looked at as compensa-
tory genomic events with assumed beneﬁcial advantage in
Table 10 Microduplication syndromes.
Syndrome Clinical features Cytogenetic location
Neonatal epilepsy microduplication syndrome 2q24.2-q24.3
Parkinson disease 1 4q22.1
Adult-onset autosomal dominant leukodystrophy Autonomic abnormalities (postural
hypotension, neurogenic bladder, and rectal
incontinence), pyramidal and cerebellar
dysfunction, symmetric demyelination of the
CNS.
5q23.2
Pseudo trisomy 13 syndrome Holoprosencephaly, postaxial polydactyly,
cardiac defects, genital anomalies, facial
dysmorphism.
5q35.1
Transient neonatal diabetes mellitus Insulin-requiring hyperglycemia within the
ﬁrst month of life, most cases resolve at age of
3 months, the rest have a permanent form of
diabetes type II.
6q24.2
Parkinson disease 2 6q26
Chondroma 6q27
Williams-Beuren region duplication syndrome Facial dysmorphism, psychomotor and
developmental delay, severe impairment in
expressive language, epilepsy.
7q11.23
Beckwith–Wiedemann syndrome 11p15
Charcot-Marie-Tooth Type 1A 17p11.2
Potocki–Lupski syndrome Autism, mental retardation, attention-deﬁcit
disorder, obsessive-compulsive behavior,
infantile hypotonia, cardiac malformations,
short stature
17p11.2
Triphalangeal thumb polysyndactyly syndrome 7q36.3
Split-hand/foot malformation 3 10q24.32
Silver-Russell syndrome 11p15.5
Spinocerebellar ataxia type 20 11q12.2q12.3
Miller–Dieker microduplication syndrome 17p13.3
Charcot-Marie-Tooth Type 1A 17p12
Neuroﬁbromatosis 1 17q11
Sotos-like syndrome 19p13.2
Down syndrome/DS 21q22.13
Cat-Eye microduplication syndrome 22p11.1-q11.21
Pelizaeus–Merzbacher microduplication
(X-linked recessive hypomyelinative leukodystrophy)
Spasticity of the legs and later the arms,
cerebellar ataxia, dementia, parkinsonian
symptoms.
Xq22.2
17-beta-hydroxysteroid dehydrogenase Neurologic abnormalities, including
psychomotor retardation and loss of mental
and motor skills
Xp11.22
X-linked hypopituitarism Neonatal hypoglycemia, short stature,
variable deﬁciencies of other pituitary
hormones, normal mentality
Xq27.1
316 M.S.Z. Salemcases of genomic losses or stresses, they result in disease
phenotypes, sometimes more severe than corresponding dele-
tion phenotypes. The devastating intellectual disability that
characterizes the large majority of these diseases makes affected
patients incapable of reproduction with no chances of transmit-
ting the disease. They are examples of neither inherited nor her-
itable genetic diseases. The persistent de novo occurrence of
these genetic defects reveals a different pathogenetic mecha-
nism that, still, has no clear interpretation. The presence of dif-
ferent contiguous, mostly functionally unrelated, gene clusters
at locations of these defects might reﬂect failure of attaining
optimal genomic integrity in view of the wide intergenic, seem-
ingly functionless, segments of the genome. Though gene clus-
tering, especially in genomes of primitive organisms, might be
considered as an effective genetic economy mechanism whereby
fewer common transcription factors are needed to activatelarge number of genes, defective or deﬁcient synthesis of these
common factors may lead to multiple genetic defects of
involved clusters. Genetic clustering in large, more complex
genomes, however, has no satisfactory explanation yet.
9.3. Multifactorial disorders
Multifactorial genetic disorders refer to diseases caused by
combined actions of both an environmental factor and a
genetic component. Pathogenesis of multifactorial diseases is
attributed to the deleterious actions exerted by the environ-
mental factor, or mutagen, on a susceptible genetic back-
ground. The spectrum of these diseases is very wide in view
of the very early exposure of the zygote and descendant cells
to multitudes of intra-uterine and extra-uterine environmental
effectors that persist all through stages of embryonic and fetal
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natal life till death. Accordingly, multifactorial diseases can
develop during intra-uterine development in view of embry-
onic/fetal susceptibility to deleterious effects of mutagenic fac-
tors, particularly teratogenic mutagens, where they make their
appearance and present as congenital multifactorial diseases,
e.g. congenital malformations. Similarly, multifactorial dis-
eases can develop at any time during post-natal life as conse-
quences of somatic mutations imposed by the persistent and
everlasting every day exposure of human cells to the environ-
mental mutagens, viz. carcinogens/clastogens/non-speciﬁc
mutagens, present everywhere in our environment. Common
examples of acquired multifactorial diseases include non-hered-
itary cancers, immunodeﬁciency disorders, coronary heart dis-
ease, hypertension, diabetes mellitus, schizophrenia, peptic
ulcer disease, tuberculosis, psoriasis and many others.
In this respect, genetic diseases can be classiﬁed into purely
genetic disorders solely caused by mutant genes without any
participation of any environmental factors in their develop-
ment, like Duchenne myopathy, achondroplasia, hemophilia,
neuroﬁbromatosis, Down syndrome and Marfan syndrome,
and multifactorial diseases where the pathogenetic effects of
an environmental mutagen are necessary for development
and progression of the disease. The impact of the genetic sus-
ceptibility to environmental factors varies widely as regards its
nature, sex of susceptible individual and magnitude of the
genetic deviation from normal status. The nature of the genetic
deviation determines to a large extent the susceptibility to and
the possibility of developing a multifactorial disease.
Genetic deviations comprising subtle defects in DNA repair
mechanisms or mild incompetence of the immune system are
expected to progress to drastic pathological conditions, e.g.
cancer and immunodeﬁciency, upon being sufﬁciently stressed
by potent environmental mutagens, than other genetic devia-
tions involving less important or non-critical aspects of genetic
functions. For these reasons, multi-factorial disorders vary
widely as regards their rates of occurrence, sex predilection,
ethnic distribution, age of onset, phenotypic spectrum and
prognostic outcomes. However, the mere presence of suscepti-
ble individual genetic constitution does not dictate indispens-
able development of the disease unless pathogenetic exposure
of speciﬁc targeted cells to the effects of the proper mutagen
in a sufﬁcient dose at a critical time occurs.References
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